ModelEdge
Regeneron Pharmaceuticals, Inc.
REGN
Filing type
10-Q
Filing date
Oct 30, 2024
Updated
Oct 31, 2024 ยท 5:16 AM

Filing

10-QQ3

Exhibits

EX-10.1AMENDMENT NO. 3 TO MASTER AGREEMENT BETWEEN REGN AND ALNYLAMEX-31.1CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A)EX-31.2CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A)EX-32CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C SECTION 1350